Introduction: Who Should Undergo Diagnostics

Arteriovenous malformations, often called AVMs, are usually present from birth but may not cause any symptoms for many years. Because of this hidden nature, many people discover they have an AVM only when something goes wrong or during tests for completely different health concerns. Understanding when to seek diagnostic testing can make an important difference in preventing serious complications.

People who experience sudden, severe headaches that feel different from any headache they’ve had before should seek immediate medical attention. This type of headache could signal that an AVM is bleeding into the brain, which is a medical emergency. About half of all people with brain AVMs first learn about their condition when bleeding occurs, and this bleeding can lead to stroke and brain damage.^[3]

Anyone experiencing seizures without a known cause should also undergo diagnostic evaluation. Seizures are one of the most common symptoms of AVMs and occur in about a quarter of people whose AVMs cause symptoms. The average age when people first have seizures due to AVMs is around 25 years.^[2]

Other warning signs that should prompt a visit to a healthcare professional include persistent headaches that occur in the same location each time, sudden muscle weakness or paralysis, problems with vision, difficulty with speech or language, numbness or tingling sensations, dizziness, or confusion. While many of these symptoms can have other causes, they warrant proper investigation to rule out an AVM or other serious conditions.^[1][2]

Sometimes AVMs are discovered completely by accident when someone undergoes brain imaging for an unrelated health concern. Many people with AVMs experience few or no symptoms at all. In fact, up to 15 percent of people with AVMs don’t have any symptoms. For these individuals, the discovery often comes as a complete surprise during routine testing or evaluation for another medical issue.^[2][3]

People with a family history of AVMs, though rare, may want to discuss screening with their healthcare provider. While most AVMs are not inherited, there are occasional cases where they run in families. Having an open conversation with your doctor about your family medical history can help determine whether diagnostic testing is appropriate for you.^[1]

Classic Diagnostic Methods

When a doctor suspects someone might have an arteriovenous malformation, several diagnostic tests can help confirm the diagnosis and provide detailed information about the AVM’s location, size, and characteristics. These tests vary in complexity, from simple physical examinations to sophisticated imaging procedures.

Physical Examination and Initial Assessment

The diagnostic process typically begins with a thorough physical examination. During this exam, your healthcare provider will review your symptoms in detail and ask about your medical history. One specific technique doctors use is listening for a sound called a bruit. A bruit is a whooshing sound caused by blood rushing quickly through the tangled blood vessels of an AVM. It sounds similar to water rushing through a narrow pipe. The doctor uses a stethoscope to listen for this distinctive sound, which can sometimes be heard near the location of an AVM. A bruit can be so noticeable that it interferes with a person’s hearing or sleep and may cause emotional distress.^[12][17]

Imaging Tests for AVM Diagnosis

Several types of imaging tests play a crucial role in identifying and characterizing arteriovenous malformations. Each test provides different information and may be used at different stages of diagnosis and treatment planning.

Computed tomography, commonly called a CT scan, uses a series of X-rays to create detailed cross-sectional images of the brain. Think of it as taking multiple slices through the brain to see what’s inside. CT scans are particularly useful for detecting bleeding in the brain. When a CT scan is performed with a special dye injected into the bloodstream, it’s called CT angiography. This dye, known as a contrast agent, makes blood vessels show up more clearly on the images, allowing doctors to see the arteries feeding the AVM and the veins draining blood away from it in greater detail.^[8][12]

Magnetic resonance imaging, or MRI, uses powerful magnets and radio waves to create detailed images of the brain’s soft tissues. An MRI is particularly good at detecting small changes in brain tissue and can pick up on details that other tests might miss. When combined with a technique called magnetic resonance angiography, or MRA, the test can capture not just images of the AVM but also the pattern, speed, and distance of blood flow through the irregular vessels. This information helps doctors understand how the AVM is affecting normal blood circulation in the brain.^[8][12]

Both CT scans and MRIs are non-invasive tests, meaning they don’t require any surgical procedures or insertion of instruments into the body beyond a simple injection of contrast dye when needed. These tests are painless and relatively quick, though MRIs can take longer and some people find the enclosed space of the MRI machine uncomfortable.

Cerebral Angiography: The Gold Standard

While CT and MRI scans provide valuable information, cerebral angiography is considered the most detailed and accurate test for diagnosing brain AVMs. This test is also called cerebral arteriography or simply angiography. During this procedure, a long, thin tube called a catheter is inserted into an artery, usually in the groin or wrist. Using X-ray imaging for guidance, the doctor carefully threads the catheter through blood vessels until it reaches the arteries in the brain.^[8][5]

Once the catheter is properly positioned, a special dye is injected directly into the brain’s blood vessels. This dye makes the blood vessels visible on X-ray images, creating a detailed map of how blood flows through the brain. Cerebral angiography reveals critical information about the AVM, including the exact location of the feeding arteries that bring blood into the AVM and the draining veins that carry blood away from it. This information is essential for planning treatment.^[8]

The procedure can be performed with light sedation, where the patient remains awake but relaxed, or with general anesthesia, where the patient is asleep. While cerebral angiography is more invasive than CT or MRI scans, it provides the most detailed view of an AVM. However, as with any invasive test, there is a very small risk of complications, most importantly a small risk of causing a stroke. Doctors typically perform this test only when the additional detail it provides is necessary for diagnosis or treatment planning.^[5]

Additional Diagnostic Tools

Transcranial doppler ultrasound is another tool that can help diagnose AVMs and determine whether an AVM is bleeding. This test uses high-frequency sound waves aimed at arteries to create images showing blood flow and its speed. Unlike CT or MRI scans, ultrasound doesn’t use radiation and is completely non-invasive. The test is performed by placing a special device on the skin surface that sends sound waves through the skull to examine blood vessels inside the brain.^[12]

In some cases, doctors may discover AVMs incidentally during imaging tests ordered for completely unrelated reasons. Most malformations tend to be discovered only by chance, usually during treatment for another disorder or even during autopsy. This highlights how AVMs can exist silently in the body for years without causing any noticeable problems.^[2]

Diagnostics for Clinical Trial Qualification

When patients consider participating in clinical trials for arteriovenous malformation treatments, they undergo specific diagnostic evaluations to determine if they are suitable candidates. These evaluations ensure that participants meet the study’s criteria and that researchers can accurately measure the effects of experimental treatments.

Clinical trials studying new treatments for AVMs typically require comprehensive imaging documentation before enrollment. This baseline imaging serves as a reference point for measuring whether the experimental treatment is working. Patients must usually undergo cerebral angiography to establish the exact size, location, and characteristics of their AVM. This detailed mapping is essential because researchers need precise measurements to compare before and after treatment.^[8]

The classification and grading of AVMs play an important role in clinical trial qualification. Researchers often use specific grading systems to categorize AVMs based on factors like size, location, and the pattern of blood drainage. These grades help determine which patients are most likely to benefit from a particular experimental treatment and which patients might face higher risks.

Trials often have specific requirements about whether an AVM has previously bled. Some studies focus on AVMs that have never ruptured, while others specifically enroll patients who have experienced bleeding. The bleeding history significantly affects the risk profile of an AVM and influences treatment decisions. Studies have shown that the best available data suggests AVMs have a 1 to 3 percent per year risk of bleeding once discovered.^[5]

Neurological function testing is another standard component of clinical trial diagnostics. Researchers need to document a patient’s baseline neurological status, including cognitive function, motor skills, sensory abilities, and overall neurological health. This baseline assessment allows researchers to track any changes that occur during and after treatment, both positive improvements and potential side effects.

Many clinical trials require recent imaging studies, typically performed within a few months before enrollment. This ensures that researchers have current information about the AVM and that no significant changes have occurred since earlier diagnostic tests. Patients may need to repeat certain imaging tests specifically for the clinical trial, even if they had similar tests done previously.

Blood tests and general health assessments are standard requirements for most clinical trials. These tests evaluate overall health status, organ function, and the presence of any other medical conditions that might affect participation in the study or response to treatment. Researchers need to ensure that participants are healthy enough to safely undergo the experimental treatment being studied.

Documentation of symptoms is another important aspect of clinical trial qualification. Patients may be asked to complete detailed questionnaires about headaches, seizures, neurological symptoms, and how their AVM affects their daily life. This symptom documentation helps researchers understand the impact of AVMs on quality of life and measure whether experimental treatments provide meaningful benefits beyond just imaging changes.

Some trials may have age restrictions or require patients to be within a certain age range. Since AVMs are most commonly discovered in people between ages 20 and 40, and the risk of symptoms is highest between ages 30 and 50, many trials focus on these age groups. However, specific age requirements vary depending on the trial’s objectives.^[3]

The location of an AVM within the brain can also determine clinical trial eligibility. Some experimental treatments are designed for AVMs in specific brain regions or for AVMs that meet certain size criteria. Researchers use detailed imaging to confirm that a patient’s AVM matches the characteristics needed for the study.

Patients interested in clinical trials should discuss their diagnostic results thoroughly with their healthcare team. The team can help interpret which trials might be appropriate based on the specific characteristics of their AVM and their overall health status. Clinical trial participation offers access to cutting-edge treatments, but it’s important to understand that these treatments are still being studied and may carry unknown risks alongside potential benefits.